Patient biology guides our decisions and we choose the path of maximum patient impact.

We always prioritize action over inertia, even when navigating complex shifts.

We execute all the way and don’t leave work half-finished.

We optimize collaboration over individual agendas, egos, or functional silos to succeed.

We embrace adversity and emerge stronger from the challenges we overcome.

OncoPrecision is a next-generation oncology therapeutics company leveraging large-scale, patient-derived biology and AI-enhanced discovery platforms to develop precision medicines with a higher probability of clinical success. The company integrates translational biology, machine learning, and modular ADC/BsAb engineering to build a pipeline of first-in-class interventions across hematologic malignancies and solid tumors.

Biotechnology

Therapeutics

OncoPrecision

OncoPrecision's headquarters in New York, NY, United States

��

People (3)

Jobs (0)

Other teams

Antibody Discovery & Development

Operations

Clinical Research

Founders

Admin

��������